|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/00 | (2006.01) |
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2691417 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12710732.4 |
| Date of filing the European patent application | 2012-03-27 | |
| (97) | Date of publication of the European application | 2014-02-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-01 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (86) | Number | PCT/EP2012/055393 |
| Date | 2012-03-27 |
| (87) | Number | WO 2012/130831 |
| Date | 2012-10-04 |
| (30) | Number | Date | Country code |
| 11160251 | 2011-03-29 | EP |
| (72) |
BAEHNER, Monika, DE
JENEWEIN, Stefan, DE
KUBBIES, Manfred, DE
MOESSNER, Ekkehard, CH
SCHLOTHAUER, Tilman, DE
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūno Fc variantai |
| ANTIBODY FC VARIANTS |
| Payment date | Validity (years) | Amount | |
| 2025-02-18 | 14 | 289.00 EUR |
| 2026-03-27 |